J Korean Ophthalmol Soc > Volume 59(1); 2018 > Article
Journal of the Korean Ophthalmological Society 2018;59(1):98-103.
DOI: https://doi.org/10.3341/jkos.2018.59.1.98    Published online January 15, 2018.
A Case of Moyamoya Syndrome Diagnosed by Ophthalmic Examination in a Patient with Moyamoya Disease.
Won Hyuk Oh
Department of Ophthalmology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. brio17@naver.com
모야모야병 환자에서 안과검사를 통해 모야모야증후군으로 진단한 1예
오원혁
인제대학교 의과대학 상계백병원 안과학교실
Correspondence:  Won Hyuk Oh,
Email: brio17@naver.com
Received: 2 November 2017   • Revised: 5 December 2017   • Accepted: 26 December 2017
Abstract
PURPOSE
To report a case of moyamoya syndrome after an additional diagnosis of neurofibromatosis type 1 (NF 1) using an ophthalmic examination in a middle-aged patient with moyamoya disease. CASE SUMMARY: A 60-year-old male with no specific past medical history except moyamoya disease visited our hospital for an ophthalmic examination. Two years prior, he had been diagnosed with moyamoya disease by brain imaging performed after a head trauma. At the first visit, his best corrected visual acuity was no light perception in the right eye (OD) and 20/25 in the left eye (OS). The intraocular pressure was 8 mmHg (OD) and 10 mmHg (OS). On fundus examination, the right eye showed a dense opacity of an ocular media and the left eye showed no abnormality except an increased cup-to-disc ratio. However, infrared imaging showed multiple whitish lesions in the left eye. Fluorescein angiography showed a patchy choroidal filling delay. During the follow-up, slit-lamp microscopy revealed Lisch nodules and multiple café au lait spots and neurofibromas were found in the skin which led to the diagnosis of NF 1. CONCLUSIONS: When examining patients with moyamoya disease, ophthalmologists should check not only ocular comorbidity associated with moyamoya disease but also ocular comorbidity with other systemic diseases that can accompany moyamoya disease. NF 1 is the most common systemic disease associated with moyamoya syndrome. In this case, appropriate follow-up was essential to monitor the development of ocular or systemic vasculopathies and their complications.
Key Words: Choroidal nodule;Moyamoya syndrome;Neurofibromatosis type 1;Vasculopathy


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2021 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next